Membranoproliferative glomerulonephritis future or investigational therapies

Todays treatment of Membranoproliferative Glomerulonephritis is going to focus on monoclonal antibodies such as Rituximab, which is one of the most effective treatment.^[1]

References

↑ Michael Rudnicki. “Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies”. BioMed Research International.

Template:WH Template:WS

[1] Michael Rudnicki. “Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies”. BioMed Research International.

[1]